HOME >> BIOLOGY >> NEWS
Promising cell protein may play role in infection and dry eye

Plasminogen Activator Inhibitor Type 2 (PAI-2), a protein found in various cell types including the skin, has been discovered in the tissue covering the eye and may have future clinical implications in various pathologies of the ocular surface such as eye infection or dry eye, according to researchers at the University of Pennsylvania and Temple University.

The researchers, led by Mina Massaro-Giordano, M.D., of the University of Pennsylvania's Scheie Eye Institute, and Marcella Macaluso, Ph.D., of the Sbarro Institute for Cancer Research at Temple University (www.shro.org), published their study,

"Cytoplasmic and nuclear interaction between Rb family proteins and PAI-2: a physiological crosstalk in human corneal and conjunctival epithelial cells," in Cell Death and Differentiation (www.nature.com/cdd).

They recently presented their findings at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Florida, which was attended by over 10,000 researchers.

PAI-2, in either extracellular or secreted form, is a multifunctional protein that plays a role in cell differentiation, in prevention of programmed cell death, in the regulation of cell proliferation, in the inhibition of microbial proteinases and in the protection against stromal degradation.

High levels of the PAI-2 protein are associated with a good prognosis in breast cancer, small cell lung, ovarian cancer, and inhibition of metastasis. PAI-2 also plays a role in inflammation on the surface of the eye.

In their study, the Penn and Temple researchers demonstrate for the first time an interaction between PAI-2 and the tumor suppressing gene Rb2/p130 in the nucleus of the epithelial cells in the cornea and conjunctiva.

According to the researchers, this interaction with Rb2/p130 and chromatin modeling enzymes may affect how PAI-2 is expressed. <
'"/>

Contact: Preston M. Moretz
pmoretz@temple.edu
215-204-7476
Temple University
16-May-2006


Page: 1 2

Related biology news :

1. Promising protein may prevent eye damage in premature babies
2. Tailored treatments: Promising designer drug provides new insight into cancer biology
3. Promising antiobesity drug fails to produce clinically meaningful weight loss
4. Promising preclinical results with live attenuated H5N1 vaccines
5. Promising new research on hereditary diseases
6. Promising anti-TB compound finally can be synthesized with ease
7. Promising results in the battle against incurable ALS muscle disease
8. Promising new preventative treatment option for population of men at high risk of prostate cancer
9. Penn researchers discover how key protein stops inflammation
10. UCF research links proteins, stem cells and potential Alzheimers treatment
11. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2019)... ... February 12, 2019 , ... Ava, a 115-pound Newfoundland, found herself in a ... her cruciate ligaments. Just one year later, she suffered the same injury in ... without surgical intervention and resumed her normal activities without any noticeable pain. Then, ...
(Date:2/11/2019)... ... February 11, 2019 , ... ... (ADM), completing the phased release of the Allotrope™ Framework for standardizing scientific data ... the previously released Allotrope™ Data Format (ADF) and application programming interfaces (APIs), and ...
(Date:2/2/2019)... ... January 31, 2019 , ... Pharmica ... toward clinical operations executives and focusing on all facets of clinical trial planning ... management, portfolio management, resource management, patient engagement, and more. , “We have ...
Breaking Biology News(10 mins):
(Date:2/2/2019)... ... January 31, 2019 , ... Dust off your Doc Martens, ... hosts the Nuriv 2019 Expo West Music and Tech Festival at the ESports Arena ... innovation in the natural foods, beverages, and dietary supplement industries, the Nuriv Music and ...
(Date:1/30/2019)... ... January 29, 2019 , ... Mr. ... 2016. In his position as Director of Sales and Marketing, Mr. Schieving was ... across multiple industries the company supports. During this time, Mr. Schieving was responsible ...
(Date:1/30/2019)... (PRWEB) , ... January 30, 2019 , ... ... in microbial genomics, has awarded microbiome research support in study design, planning, sample ... University led by Dr. Marc D. Cook, PhD, to study the interactions between ...
(Date:1/24/2019)... ... January 22, 2019 , ... Outsourcing trials to contract ... of assumptions, and RFP creation and management generally requires manual effort. Additionally, each ... to oranges. These challenges can ultimately lead to study start delays and change ...
Breaking Biology Technology:
Cached News: